|
US3159547A
(en)
|
1963-06-28 |
1964-12-01 |
Abbott Lab |
Method of lowering blood pressure with 4-(2-amino-4-pyrimidylamino)-benzene-sulfonamide
|
|
US3320256A
(en)
|
1965-04-09 |
1967-05-16 |
Hoffmann La Roche |
Fluorinated imidazoo[1, 2-c]pyrimidines and pyrimido[1, 2-c]pyrimidines
|
|
US4166452A
(en)
*
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
*
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
JPS5845466A
(ja)
|
1981-09-10 |
1983-03-16 |
松下電器産業株式会社 |
空気調和機
|
|
GR80171B
(en)
|
1983-08-29 |
1985-01-02 |
Ciba Geigy Ag |
N-(2-nitrophenyl)-4-aminopyrimidine derivatives process for the preparation thereof and use
|
|
HU192875B
(en)
|
1984-10-05 |
1987-07-28 |
Richter Gedeon Vegyeszet |
Process for preparing 2-pyridinethiol derivatives
|
|
WO1987000834A1
(en)
*
|
1985-08-02 |
1987-02-12 |
Leo Pharmaceutical Products Ltd. A/S |
Novel vitamin d analogues
|
|
DE3618353A1
(de)
|
1986-05-31 |
1987-12-03 |
Hoechst Ag |
Schaedlingsbekaempfungsmittel auf der basis von aminopyrimidin-derivaten sowie neue aminopyrimidin-verbindungen
|
|
DE3868287D1
(de)
|
1987-04-02 |
1992-03-19 |
Ciba Geigy Ag |
Reaktivfarbstoffe, deren herstellung und verwendung.
|
|
SU1499883A1
(ru)
|
1987-11-24 |
1991-10-23 |
Научно-исследовательский институт фармакологии АМН СССР |
Дихлоргидрат 2,4-бис-(п-трет-бутиланилино)-5-окси-6-метилпиримидина, обладающий анальгетической и противовоспалительной активностью
|
|
US5206229A
(en)
*
|
1988-04-21 |
1993-04-27 |
Leo Pharmaceutical Products Ltd |
Vitamin d analogues
|
|
HU206337B
(en)
|
1988-12-29 |
1992-10-28 |
Mitsui Petrochemical Ind |
Process for producing pyrimidine derivatives and pharmaceutical compositions
|
|
US4969781A
(en)
*
|
1989-04-07 |
1990-11-13 |
The B. F. Goodrich Company |
Blind fastener hand tool
|
|
IE63502B1
(en)
|
1989-04-21 |
1995-05-03 |
Zeneca Ltd |
Aminopyrimidine derivatives useful for treating cardiovascular disorders
|
|
US4983608A
(en)
|
1989-09-05 |
1991-01-08 |
Hoechst-Roussell Pharmaceuticals, Inc. |
N-substituted-4-pyrimidinamines and pyrimidinediamines
|
|
US5179204A
(en)
|
1989-09-05 |
1993-01-12 |
Hoechst-Roussel Pharmaceuticals Incorporated |
N-substituted-4-pyrimidinamines and pyrimidinediamines
|
|
JPH03127790A
(ja)
|
1989-10-11 |
1991-05-30 |
Morishita Pharmaceut Co Ltd |
N―(1h―テトラゾール―5―イル)―2―アニリノ―5―ピリミジンカルボキシアミド類及びその合成中間体
|
|
TW224941B
(cg-RX-API-DMAC7.html)
|
1989-11-08 |
1994-06-11 |
Yamanouchi Pharma Co Ltd |
|
|
US5532228A
(en)
*
|
1990-02-06 |
1996-07-02 |
Schering Aktiengesellschaft |
Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
|
|
DE4011682A1
(de)
*
|
1990-04-06 |
1991-10-10 |
Schering Ag |
24-oxa-derivate in der vitamin d-reihe
|
|
GB9012592D0
(en)
|
1990-06-06 |
1990-07-25 |
Smithkline Beecham Intercredit |
Compounds
|
|
DE4029650A1
(de)
|
1990-09-19 |
1992-03-26 |
Hoechst Ag |
2-anilino-pyrimidine, verfahren zu ihrer herstellung, sie enthaltene mittel und ihre verwendung als fungizide
|
|
JPH04178385A
(ja)
|
1990-11-09 |
1992-06-25 |
Yamanouchi Pharmaceut Co Ltd |
ジケトピリドピラジン誘導体
|
|
EP0522606B1
(en)
*
|
1991-05-10 |
1996-04-03 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, their production and use
|
|
US5200400A
(en)
*
|
1991-07-12 |
1993-04-06 |
New England Deaconess Hospital Corporation |
Method for inhibiting allograft rejection using photoactivatable nucleotides or nucleosides
|
|
CA2074864A1
(en)
|
1991-07-30 |
1993-01-31 |
Carmen Almansa |
Tetralones with pharmacological activity
|
|
US5728536A
(en)
|
1993-07-29 |
1998-03-17 |
St. Jude Children's Research Hospital |
Jak kinases and regulation of Cytokine signal transduction
|
|
DE4141746A1
(de)
*
|
1991-12-13 |
1993-06-17 |
Schering Ag |
20-methyl-substituierte vitamin d-derivate
|
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
US5194431A
(en)
*
|
1992-07-08 |
1993-03-16 |
Wisconsin Alumni Research Foundation |
24-cyclopropane vitamin D derivatives
|
|
TW287160B
(cg-RX-API-DMAC7.html)
|
1992-12-10 |
1996-10-01 |
Hoffmann La Roche |
|
|
NZ274978A
(en)
|
1993-10-12 |
1998-04-27 |
Du Pont Merck Pharma |
1n-alkyl-n-aryl pyrimidinamine derivatives and pharmaceutical compositions thereof
|
|
IL112290A
(en)
|
1994-01-12 |
1999-01-26 |
Novartis Ag |
Transformed aryl and the troiryl pyrimidines and herbicides containing them
|
|
US5585381A
(en)
|
1994-06-01 |
1996-12-17 |
Kureha Chemical Industry Co., Ltd. |
Pyrimidine derivatives and pharmaceutical composition
|
|
US5733932A
(en)
|
1995-01-06 |
1998-03-31 |
The Picower Institute For Medical Research |
Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
|
|
US6242434B1
(en)
*
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
|
US6316635B1
(en)
*
|
1995-06-07 |
2001-11-13 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
|
US5700904A
(en)
|
1995-06-07 |
1997-12-23 |
Eli Lilly And Company |
Preparation of an acylated protein powder
|
|
GB9516121D0
(en)
|
1995-08-05 |
1995-10-04 |
Pfizer Ltd |
Organometallic addition to ketones
|
|
JP2002515023A
(ja)
|
1995-08-24 |
2002-05-21 |
ビーエーエスエフ アクチェンゲゼルシャフト |
N−複素環化合物、その製造用中間体、それを含む組成物及び有害菌類防除にそれを使用する方法
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JP4058129B2
(ja)
*
|
1996-03-18 |
2008-03-05 |
株式会社資生堂 |
ピリジン誘導体及び抗潰瘍剤、抗菌剤
|
|
TW440563B
(en)
|
1996-05-23 |
2001-06-16 |
Hoffmann La Roche |
Aryl pyrimidine derivatives and a pharmaceutical composition thereof
|
|
US6696448B2
(en)
*
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
|
GB9619284D0
(en)
|
1996-09-16 |
1996-10-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6004985A
(en)
|
1996-10-09 |
1999-12-21 |
Berlex Laboratories, Inc. |
Thio acid derived monocylic N-heterocyclics as anticoagulants
|
|
ES2301194T3
(es)
|
1997-02-05 |
2008-06-16 |
Warner-Lambert Company Llc |
Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular.
|
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6316429B1
(en)
*
|
1997-05-07 |
2001-11-13 |
Sugen, Inc. |
Bicyclic protein kinase inhibitors
|
|
US6486185B1
(en)
*
|
1997-05-07 |
2002-11-26 |
Sugen, Inc. |
3-heteroarylidene-2-indolinone protein kinase inhibitors
|
|
US6987113B2
(en)
*
|
1997-06-11 |
2006-01-17 |
Sugen, Inc. |
Tyrosine kinase inhibitors
|
|
SE9702401D0
(sv)
*
|
1997-06-19 |
1997-06-19 |
Astra Ab |
Pharmaceutical use
|
|
GB9718913D0
(en)
*
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
|
US6133305A
(en)
*
|
1997-09-26 |
2000-10-17 |
Sugen, Inc. |
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
|
|
US6093820A
(en)
*
|
1997-10-02 |
2000-07-25 |
Taro Pharmaceutical Industries Ltd. |
Method and reagents for N-alkylating ureides
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
GB9723859D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Compound,composition and use
|
|
DE19750701A1
(de)
|
1997-11-15 |
1999-05-20 |
Dystar Textilfarben Gmbh & Co |
Verfahren zur Umsetzung von fluorsubstituierten Heterocyclen mit Aminen in Gegenwart von Phasentransfer-Katalysatoren
|
|
ATE401312T1
(de)
|
1997-12-15 |
2008-08-15 |
Astellas Pharma Inc |
Pyrimidin-5-carboxamid-derivate
|
|
AU754965B2
(en)
|
1997-12-31 |
2002-11-28 |
University Of Kansas, The |
Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
|
|
PT1054874E
(pt)
*
|
1998-02-13 |
2003-01-31 |
Upjohn Co |
Derivados de aminofenil-isoxazolina substituidos uteis como anti-microbianos
|
|
ATE245641T1
(de)
|
1998-02-17 |
2003-08-15 |
Tularik Inc |
Antivirale pyrimidinderivate
|
|
WO1999047529A1
(en)
|
1998-03-18 |
1999-09-23 |
Ariad Pharmaceuticals, Inc. |
Heterocyclic signal transduction inhibitors, compositions containing them
|
|
BRPI9909191B8
(pt)
|
1998-03-27 |
2021-07-06 |
Janssen Pharmaceutica Nv |
derivados de pirimidina inibidores do hiv, seu uso e composição farmacêutica que os compreende
|
|
NZ506679A
(en)
|
1998-03-27 |
2002-11-26 |
Janssen Pharmaceutica Nv |
HIV inhibiting pyrimidine derivatives
|
|
GB9806739D0
(en)
|
1998-03-28 |
1998-05-27 |
Univ Newcastle Ventures Ltd |
Cyclin dependent kinase inhibitors
|
|
WO1999050249A2
(en)
|
1998-04-01 |
1999-10-07 |
Du Pont Pharmaceuticals Company |
Pyrimidines and triazines as integrin antagonists
|
|
DE69933661T3
(de)
*
|
1998-04-15 |
2012-01-26 |
Merck Serono Biodevelopment |
Genomische sequenz des 5-lipoxygenase-aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
|
|
BR9910621A
(pt)
|
1998-05-22 |
2001-01-30 |
Smithkline Beecham Corp |
Novos compostos de imidazol 2-alquil substituìdos
|
|
JP2004504259A
(ja)
|
1998-06-30 |
2004-02-12 |
パーカー ヒューズ インスティテュート |
Jak−3インヒビターを用いたc−jun発現の阻害方法
|
|
AU5682799A
(en)
|
1998-08-21 |
2000-03-14 |
Parker Hughes Institute |
Quinazoline derivatives
|
|
AU5438299A
(en)
|
1998-08-29 |
2000-03-21 |
Astrazeneca Ab |
Pyrimidine compounds
|
|
DE19851421A1
(de)
|
1998-11-07 |
2000-05-11 |
Boehringer Ingelheim Pharma |
Neue Pyrimidine, deren Herstellung und Verwendung
|
|
ID28376A
(id)
|
1998-11-10 |
2001-05-17 |
Janssen Pharmaceutica Nv |
Pirimidina yang menghambat replikasi hiv
|
|
EP1129068A1
(en)
*
|
1998-11-12 |
2001-09-05 |
Ariad Pharmaceuticals, Inc. |
Bicyclic signal transduction inhibitors, composition containing them and uses thereof
|
|
US6127376A
(en)
|
1998-12-04 |
2000-10-03 |
Berlex Laboratories, Inc. |
Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
|
|
GB9828511D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
US6841567B1
(en)
|
1999-02-12 |
2005-01-11 |
Cephalon, Inc. |
Cyclic substituted fused pyrrolocarbazoles and isoindolones
|
|
US6673908B1
(en)
*
|
1999-02-22 |
2004-01-06 |
Nuvelo, Inc. |
Tumor necrosis factor receptor 2
|
|
GB9904995D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Substituted aza-oxindole derivatives
|
|
US6624171B1
(en)
*
|
1999-03-04 |
2003-09-23 |
Smithkline Beecham Corporation |
Substituted aza-oxindole derivatives
|
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
SE9901079D0
(sv)
|
1999-03-23 |
1999-03-23 |
Astra Ab |
Novel compounds
|
|
AU4157500A
(en)
|
1999-03-26 |
2000-10-16 |
Astrazeneca Ab |
Novel compounds
|
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
|
EP1165522A1
(en)
|
1999-04-06 |
2002-01-02 |
Krenitsky Pharmaceuticals, Inc. |
Neurotrophic thio substituted pyrimidines
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
DE19917785A1
(de)
|
1999-04-20 |
2000-10-26 |
Bayer Ag |
2,4-Diamino-pyrimidin-Derivate
|
|
AU5108000A
(en)
|
1999-06-10 |
2001-01-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
GB9914258D0
(en)
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
EP1206265B1
(en)
|
1999-06-30 |
2003-11-12 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
TWI262914B
(en)
*
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
|
JP2003509425A
(ja)
|
1999-09-15 |
2003-03-11 |
ワーナー−ランバート・カンパニー |
キナーゼ阻害剤としてのプテリジノン
|
|
TR200200763T2
(tr)
|
1999-09-24 |
2003-09-22 |
Janssen Pharmaceutica N.V. |
Antiviral bileşimler
|
|
DE19945982A1
(de)
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Geschwindigkeitsbestimmte Partikel
|
|
AU7738000A
(en)
|
1999-09-30 |
2001-04-30 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
KR100317935B1
(ko)
|
1999-10-20 |
2001-12-22 |
유승필 |
대사성 골질환 치료용 약제조성물 및 이의 제조방법
|
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
AU1026901A
(en)
|
1999-10-29 |
2001-05-08 |
Syngenta Participations Ag |
Novel herbicides
|
|
AU4903201A
(en)
|
1999-11-30 |
2001-07-03 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
OA12118A
(en)
|
1999-12-10 |
2006-05-04 |
Pfizer Prod Inc |
PyrroloÄ2,3-dÜpyrimidine compounds.
|
|
US6610688B2
(en)
*
|
1999-12-21 |
2003-08-26 |
Sugen, Inc. |
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
|
|
CA2396693A1
(en)
|
1999-12-28 |
2001-07-05 |
Stephen T. Wrobleski |
Cytokine, especially tnf-alpha, inhibitors
|
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
|
US6362172B2
(en)
|
2000-01-20 |
2002-03-26 |
Bristol-Myers Squibb Company |
Water soluble prodrugs of azole compounds
|
|
AU2968701A
(en)
|
2000-01-24 |
2001-07-31 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the uses thereof
|
|
JP4739632B2
(ja)
|
2000-02-05 |
2011-08-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Erkのインヒビターとして有用なピラゾール組成物
|
|
JP4783532B2
(ja)
*
|
2000-02-05 |
2011-09-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Erkのインヒビターとして有用なピラゾール組成物
|
|
KR20030024659A
(ko)
|
2000-02-17 |
2003-03-26 |
암겐 인코포레이티드 |
키나제 억제제
|
|
GB0004886D0
(en)
*
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
US6525051B2
(en)
|
2000-03-27 |
2003-02-25 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
|
US6608048B2
(en)
*
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
CA2406562C
(en)
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Hiv replication inhibiting pyrimidines and triazines
|
|
US7034019B2
(en)
|
2000-05-08 |
2006-04-25 |
Janssen Pharmaceutica N.V. |
Prodrugs of HIV replication inhibiting pyrimidines
|
|
OA12292A
(en)
|
2000-06-26 |
2003-11-11 |
Pfizer Prod Inc |
PyrroloÄ2,3-dÜpyrimidine compounds as immunosuppressive agents.
|
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
|
US20050009876A1
(en)
*
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
|
DE60118576T2
(de)
|
2000-08-18 |
2006-11-02 |
3M Innovative Properties Co., Saint Paul |
Fluoro(meth)acrylatecopolymer-beschichtungsmassen
|
|
AU2001290912A1
(en)
|
2000-09-15 |
2002-03-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
DE60121986T2
(de)
*
|
2000-10-02 |
2007-07-26 |
Emory University |
Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen
|
|
US6448401B1
(en)
*
|
2000-11-20 |
2002-09-10 |
Bristol-Myers Squibb Company |
Process for water soluble azole compounds
|
|
AU2001229722A1
(en)
|
2000-11-29 |
2002-06-11 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
US20020115173A1
(en)
*
|
2000-12-11 |
2002-08-22 |
Children's Medical Center Corporation |
Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity
|
|
EP1351691A4
(en)
|
2000-12-12 |
2005-06-22 |
Cytovia Inc |
SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF
|
|
PE20020776A1
(es)
*
|
2000-12-20 |
2002-08-22 |
Sugen Inc |
Indolinonas 4-aril sustituidas
|
|
BR0116493A
(pt)
|
2000-12-21 |
2003-09-30 |
Vertex Pharma |
Compostos de pirazol úteis como inibidores de proteìna cinase
|
|
MXPA03005696A
(es)
|
2000-12-21 |
2003-10-06 |
Glaxo Group Ltd |
Pirimidinaminas como moduladores de angiogenesis.
|
|
AUPR279101A0
(en)
*
|
2001-01-30 |
2001-02-22 |
Cytopia Pty Ltd |
Protein kinase signalling
|
|
WO2002060492A1
(en)
|
2001-01-30 |
2002-08-08 |
Cytopia Pty Ltd |
Methods of inhibiting kinases
|
|
AU2002258400A1
(en)
|
2001-02-16 |
2002-08-28 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
BR0207096A
(pt)
|
2001-02-20 |
2004-01-20 |
Astrazeneca Ab |
Uso de um composto, compostos, formulação farmacêutica, e, método de tratamento e/ou profilaxia de condições associadas com a inibição de glicogênio sintase quinase-3
|
|
MXPA03007621A
(es)
|
2001-02-23 |
2003-12-04 |
Merck & Co Inc |
Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
|
|
GB2373186A
(en)
|
2001-02-23 |
2002-09-18 |
Astrazeneca Ab |
Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
|
|
ATE497603T1
(de)
*
|
2001-03-02 |
2011-02-15 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
|
IL159120A0
(en)
|
2001-05-29 |
2004-05-12 |
Schering Ag |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments
|
|
WO2002096905A1
(en)
|
2001-06-01 |
2002-12-05 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinases
|
|
MXPA03010961A
(es)
*
|
2001-05-31 |
2004-02-27 |
Vertex Pharma |
Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
|
|
US7301023B2
(en)
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
|
CA2450769A1
(en)
|
2001-06-15 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
EP1408978A4
(en)
|
2001-06-21 |
2005-07-13 |
Ariad Pharma Inc |
NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
HRP20031049A2
(en)
*
|
2001-06-23 |
2004-06-30 |
Aventis Pharma Inc |
Pyrrolopyrimidines as protein kinase inhibitors
|
|
AU2002316421B2
(en)
|
2001-06-26 |
2008-05-15 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-ALPHA expression
|
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
|
US6433018B1
(en)
*
|
2001-08-31 |
2002-08-13 |
The Research Foundation Of State University Of New York |
Method for reducing hypertrophy and ischemia
|
|
US7070996B2
(en)
*
|
2001-08-31 |
2006-07-04 |
Rigel Pharmaceuticals, Inc. |
Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
|
|
AU2002334355A1
(en)
|
2001-09-06 |
2003-03-18 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
|
JP2005506982A
(ja)
*
|
2001-09-10 |
2005-03-10 |
スージェン・インコーポレーテッド |
キナーゼ阻害剤としての3−(4,5,6,7−テトラヒドロインドール−2−イルメチリデン)−2−インドリノン誘導体
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
WO2003026665A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
|
|
WO2003040141A1
(en)
|
2001-09-28 |
2003-05-15 |
Bayer Pharmaceuticals Corporation |
Oxazolyl-phenyl-2,4-diamino-pyrimidine compounds and methods for treating hyperproliferative disorders
|
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
JP4460292B2
(ja)
|
2001-10-17 |
2010-05-12 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
ピリミジン誘導体、これらの化合物を含む医薬組成物、その使用及びその調製方法
|
|
US6897208B2
(en)
*
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
|
IL162210A0
(en)
|
2001-11-28 |
2005-11-20 |
Btg Int Ltd |
Preventives or remedies for alzheimer's disease oramyloid protein fibrosis inhibitors containing ni trogen-containing heteroaryl
|
|
PY0228255A
(es)
|
2001-12-06 |
2004-06-01 |
Pfizer Prod Inc |
Compuestos cristalinos novedosos
|
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
|
WO2003055489A1
(en)
|
2001-12-21 |
2003-07-10 |
Bayer Pharmaceuticals Corporation |
2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
US20030158195A1
(en)
*
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
|
MXPA04007191A
(es)
|
2002-01-23 |
2005-03-31 |
Bayer Pharmaceuticals Corp |
Derivados de pirimidina como inhibidores de rho-quinasa.
|
|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
US6998391B2
(en)
*
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
US7459455B2
(en)
|
2002-02-08 |
2008-12-02 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
CA2477505A1
(en)
|
2002-03-01 |
2003-09-12 |
Smithkline Beecham Corporation |
Diamino-pyrimidines and their use as angiogenesis inhibitors
|
|
JP2005526765A
(ja)
|
2002-03-11 |
2005-09-08 |
シエーリング アクチエンゲゼルシャフト |
Cdk−阻害性2−ヘテロアリール−ピリミジン類、それらの生成及び医薬としての使用
|
|
US7288547B2
(en)
|
2002-03-11 |
2007-10-30 |
Schering Ag |
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
GEP20074230B
(en)
|
2002-03-20 |
2007-11-12 |
Bristol Myers Squibb Co |
Phosphate prodrugs of fluorooxindoles
|
|
AU2003301758A1
(en)
|
2002-05-06 |
2004-05-25 |
Bayer Pharmaceuticals Corporation |
Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
|
|
WO2003095448A1
(en)
|
2002-05-06 |
2003-11-20 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
AR039540A1
(es)
|
2002-05-13 |
2005-02-23 |
Tibotec Pharm Ltd |
Compuestos microbicidas con contenido de pirimidina o triazina
|
|
CA2487679A1
(en)
*
|
2002-05-30 |
2003-12-11 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of jak and cdk2 protein kinases
|
|
WO2003106451A1
(en)
|
2002-06-14 |
2003-12-24 |
Altana Pharma Ag |
Substituted diaminopyrimidines
|
|
AU2003276125B2
(en)
|
2002-06-17 |
2007-05-17 |
Smithkline Beecham Corporation |
Chemical process
|
|
ES2373226T3
(es)
|
2002-06-28 |
2012-02-01 |
Astellas Pharma Inc. |
Derivado de diaminopirimidincarboxamida.
|
|
US6758434B2
(en)
*
|
2002-07-03 |
2004-07-06 |
Kimberly-Clark Worldwide, Inc. |
Dispenser for multiple rolls of sheet material
|
|
WO2004009957A1
(en)
|
2002-07-23 |
2004-01-29 |
Halliburton Energy Services, Inc. |
Subterranean well pressure and temperature measurement
|
|
IL166241A0
(en)
*
|
2002-07-29 |
2006-01-15 |
Rigel Pharmaceuticals Inc |
Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds
|
|
WO2004014384A2
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
|
|
AU2003262642B2
(en)
|
2002-08-14 |
2010-06-17 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
DE10243291B4
(de)
*
|
2002-09-18 |
2015-04-30 |
Mann + Hummel Gmbh |
Ventil, insbesondere für den Ölkreislauf einer Brennkraftmaschine
|
|
EP1562911B1
(en)
|
2002-11-01 |
2010-01-06 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of jak and other protein kinases
|
|
US7259161B2
(en)
|
2002-11-04 |
2007-08-21 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
US7348335B2
(en)
|
2002-11-05 |
2008-03-25 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
GB0226582D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Anti-viral compounds
|
|
AR042052A1
(es)
*
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
|
RS20050380A
(sr)
|
2002-11-21 |
2007-11-15 |
Pfizer Products Inc., |
Derivati 3-aminopiperidina i postupci njihove proizvodnje
|
|
WO2004047843A1
(en)
|
2002-11-26 |
2004-06-10 |
Pfizer Products Inc. |
Method of treatment of transplant rejection
|
|
WO2004048343A1
(en)
|
2002-11-28 |
2004-06-10 |
Schering Aktiengesellschaft |
Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
|
|
AU2002350719A1
(en)
|
2002-11-29 |
2004-06-23 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
|
KR20050084224A
(ko)
|
2002-12-09 |
2005-08-26 |
더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
야누스 티로신 키나제 3을 선택적으로 저해하는 방법
|
|
JPWO2004054617A1
(ja)
|
2002-12-13 |
2006-04-20 |
協和醗酵工業株式会社 |
中枢疾患の予防および/または治療剤
|
|
US7226919B2
(en)
|
2002-12-18 |
2007-06-05 |
Vertex Pharmaceuticals Inc. |
Compositions useful as inhibitors of protein kinases
|
|
US7098332B2
(en)
*
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
EP1590334B1
(en)
|
2003-01-30 |
2009-08-19 |
Boehringer Ingelheim Pharmaceuticals Inc. |
2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
|
|
EP1597237B1
(en)
|
2003-02-07 |
2016-07-27 |
Janssen Pharmaceutica NV |
Pyrimidine derivatives for the prevention of HIV infection
|
|
ES2325440T3
(es)
|
2003-02-20 |
2009-09-04 |
Smithkline Beecham Corporation |
Compuestos de pirimidina.
|
|
CL2004000303A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
US7547794B2
(en)
*
|
2003-04-03 |
2009-06-16 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
US20050009817A1
(en)
|
2003-04-30 |
2005-01-13 |
Jennifer Savoy |
Substituted heteroaryls
|
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1651595A2
(en)
|
2003-05-30 |
2006-05-03 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
EP1651636A1
(en)
|
2003-07-10 |
2006-05-03 |
Neurogen Corporation |
Substituted heterocyclic diarylamine analogues
|
|
NZ545058A
(en)
|
2003-07-16 |
2008-05-30 |
Janssen Pharmaceutica Nv |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
ES2317031T3
(es)
|
2003-07-16 |
2009-04-16 |
Janssen Pharmaceutica Nv |
Derivados de triazolopirimidina como inhibidores de la glucogeno-sintasa-quinasa 3.
|
|
WO2005009980A1
(en)
|
2003-07-22 |
2005-02-03 |
Neurogen Corporation |
Substituted pyridin-2-ylamine analogues
|
|
US7442698B2
(en)
|
2003-07-24 |
2008-10-28 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
CN100457728C
(zh)
|
2003-07-24 |
2009-02-04 |
麦克公司 |
酪氨酸激酶抑制剂
|
|
ES2421139T3
(es)
|
2003-07-30 |
2013-08-29 |
Rigel Pharmaceuticals, Inc. |
Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
|
|
EP1648875A1
(en)
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
|
ATE455546T1
(de)
|
2003-08-06 |
2010-02-15 |
Vertex Pharma |
Aminotriazol-verbindungen als proteinkinase- hemmer
|
|
DK1663242T3
(da)
*
|
2003-08-07 |
2011-08-01 |
Rigel Pharmaceuticals Inc |
2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
|
|
EA200600225A1
(ru)
|
2003-08-14 |
2006-08-25 |
Пфайзер Инк. |
Производные пиперазина для лечения вич инфекций
|
|
ATE542801T1
(de)
|
2003-08-15 |
2012-02-15 |
Novartis Ag |
Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
US7223759B2
(en)
|
2003-09-15 |
2007-05-29 |
Anadys Pharmaceuticals, Inc. |
Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
AU2004272288B2
(en)
|
2003-09-18 |
2008-11-13 |
Novartis Ag |
2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
WO2005027848A2
(en)
|
2003-09-19 |
2005-03-31 |
Barnes-Jewish Hospital |
Methods for screening osteogenic compounds targeting syk kinase and/or vav3 and uses of syk modulators and/or vav modulators
|
|
ES2361835T3
(es)
|
2003-09-25 |
2011-06-22 |
Janssen Pharmaceutica Nv |
Derivados de purina inhibidores de la replicación del hiv.
|
|
ES2295924T3
(es)
|
2003-10-03 |
2008-04-16 |
Pfizer, Inc. |
Derivados de tropano imidazopirina sustituidos con actividad antagonista de los receptores ccr5 para el tratamiento de vih y de la inflamacion.
|
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
RU2006122853A
(ru)
|
2003-11-28 |
2008-01-10 |
Новартис АГ (CH) |
Производные диарилмочевины для лечения заболеваний, зависимых от протеинкиназы
|
|
MY141255A
(en)
|
2003-12-11 |
2010-03-31 |
Memory Pharm Corp |
Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
|
|
EP1694652A1
(en)
|
2003-12-19 |
2006-08-30 |
Rigel Pharmaceuticals, Inc. |
Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates
|
|
ES2389203T3
(es)
|
2004-01-12 |
2012-10-24 |
Ym Biosciences Australia Pty Ltd |
Inhibidores de quinasa selectivos
|
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
|
PL1713806T3
(pl)
|
2004-02-14 |
2013-09-30 |
Irm Llc |
Związki i kompozycje jako inhibitory kinaz białkowych
|
|
US7745625B2
(en)
*
|
2004-03-15 |
2010-06-29 |
Bristol-Myers Squibb Company |
Prodrugs of piperazine and substituted piperidine antiviral agents
|
|
WO2005107760A1
(en)
|
2004-04-30 |
2005-11-17 |
Irm Llc |
Compounds and compositions as inducers of keratinocyte differentiation
|
|
JP4812763B2
(ja)
|
2004-05-18 |
2011-11-09 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
|
|
EP1598343A1
(de)
*
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
|
GB0419161D0
(en)
|
2004-08-27 |
2004-09-29 |
Novartis Ag |
Organic compounds
|
|
US20060047135A1
(en)
|
2004-08-30 |
2006-03-02 |
Chadwick Scott T |
Process for preparing chloromethyl di-tert-butylphosphate
|
|
US20060058525A1
(en)
|
2004-09-01 |
2006-03-16 |
Rajinder Singh |
Synthesis of 2,4-pyrimidinediamine compounds
|
|
EP1794134A1
(de)
|
2004-09-29 |
2007-06-13 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 2-anilinopyrimidine als zellzyklus -kinase oder rezeptortyrosin-kinase inhibitoren, deren herstellung und verwendung als arzneimittel
|
|
ATE520672T1
(de)
|
2004-09-30 |
2011-09-15 |
Tibotec Pharm Ltd |
Hiv-hemmende 5-carbo- oder heterozyklisch substituierte pyrimidine
|
|
CA2584808A1
(en)
*
|
2004-10-29 |
2006-05-11 |
Rigel Pharmaceuticals, Inc. |
Substituted pyridines with activity on syk kinase
|
|
ATE540035T1
(de)
|
2004-11-24 |
2012-01-15 |
Rigel Pharmaceuticals Inc |
Spiro-2,4-pyrimidindiamin-verbindungen und ihre verwendungen
|
|
US7442716B2
(en)
|
2004-12-17 |
2008-10-28 |
Merck Frosst Canada Ltd. |
2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
|
|
US8211929B2
(en)
|
2004-12-30 |
2012-07-03 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
US7449458B2
(en)
*
|
2005-01-19 |
2008-11-11 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
JP2008540436A
(ja)
|
2005-05-03 |
2008-11-20 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jakキナーゼインヒビターおよびそれらの使用
|
|
US20060251285A1
(en)
|
2005-05-05 |
2006-11-09 |
Mrs. Yen-Chen Chan |
[surge-proof damper]
|
|
WO2006133426A2
(en)
|
2005-06-08 |
2006-12-14 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
EP1896134A2
(en)
|
2005-06-13 |
2008-03-12 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders
|
|
EA200800285A1
(ru)
|
2005-07-11 |
2008-08-29 |
Санофи-Авентис |
Новые производные 2,4-дианилинопиримидинов, их получение, лекарственные средства, фармацевтические композиции, содержащие указанные производные, и их применение, в частности, в качестве ингибиторов ikk
|
|
CA2616512A1
(en)
|
2005-07-28 |
2007-02-08 |
Intervet International B.V. |
Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof
|
|
CN101282979B
(zh)
|
2005-09-13 |
2011-09-21 |
卫材R&D管理有限公司 |
稳定性被改善的含有磷酸氯甲酯衍生物的组合物及其制备方法
|
|
WO2007053452A1
(en)
*
|
2005-11-01 |
2007-05-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US7713987B2
(en)
*
|
2005-12-06 |
2010-05-11 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2,4-diamines and their uses
|
|
EP1966207A2
(en)
|
2005-12-21 |
2008-09-10 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
TW200736232A
(en)
|
2006-01-26 |
2007-10-01 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
|
KR101411695B1
(ko)
*
|
2006-02-17 |
2014-07-03 |
리겔 파마슈티칼스, 인크. |
자가면역 질환의 치료 또는 예방을 위한 2,4-피리미딘디아민 화합물
|
|
WO2007098507A2
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US20090192158A1
(en)
|
2006-05-02 |
2009-07-30 |
Stacia Kargman |
Methods for Treating or Preventing Neoplasias
|
|
US7776855B2
(en)
|
2006-07-27 |
2010-08-17 |
Janssen Pharmaceutica N.V. |
Antimicrobial oxazolidinone prodrugs
|
|
DK2089369T3
(da)
|
2006-10-19 |
2011-05-09 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiaminderivater som hæmmere af JAK-kinaser til behandling af autoimmune sygdomme
|
|
WO2008064274A1
(en)
*
|
2006-11-21 |
2008-05-29 |
Rigel Pharmaceuticals, Inc. |
Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses
|
|
CA2670645A1
(en)
|
2006-12-19 |
2008-07-03 |
Genentech, Inc. |
Pyrimidine kinase inhibitors
|
|
PE20081636A1
(es)
|
2007-01-26 |
2009-01-10 |
Smithkline Beecham Corp |
Inhibidores de antranilamida para aurora quinasa
|
|
US7947698B2
(en)
|
2007-03-23 |
2011-05-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
|
WO2008118823A2
(en)
|
2007-03-26 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
CN101903357A
(zh)
*
|
2007-07-17 |
2010-12-01 |
里格尔药品股份有限公司 |
作为pkc抑制剂的环状胺取代的嘧啶二胺
|